Literature DB >> 544977

A method to determine dopamine levels and turnover rate in discrete dopamine nerve terminal systems by quantitative use of dopamine fluorescence obtained by Falck--Hillarp methodology.

L F Agnati, K Andersson, F Wiesel, K Fuxe.   

Abstract

In tissue sections of regions with evenly distributed dopamine (DA) nerve terminals such as the nucleus caudatus, it is possible to obtain absolute amounts (nmol/g) of DA by means of quantitative microfluorimetrical measurements of catecholamine (CA) fluorescence intensity in the tissue and in DA-containing albumin-agar standards. The values agree well with mass-fragmentographical determinations of DA. The steady-state DA levels of heterogenously innervated areas such as the tuberculum olfactorium determined by quantitative microfluorimetry can be made comparable to the steady-state levels of DA obtained by biochemistry in the entire tuberculum olfactorium by means of a conversion factor which considers the dilution of the DA-containing structures by non-DA-containing nerve cells in the biochemical analysis. This factor is obtained by making biochemical determinations in such regions of untreated animals (e.g. the tuberculum olfactorium). The results of this paper have demonstrated that the histochemical approach not only has a high power of resolution and makes it possible to perform studies on an intact morphological substrate but also allows the determination of DA steady-state (nmol/g) and DA turnover rate (nmol/g x min-1) in discrete DA nerve terminal systems of the brain in absolute amounts.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 544977     DOI: 10.1016/0165-0270(79)90025-6

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  6 in total

1.  Chronic nicotine treatment increases dopamine levels and reduces dopamine utilization in substantia nigra and in surviving forebrain dopamine nerve terminal systems after a partial di-mesencephalic hemitransection.

Authors:  K Fuxe; A M Janson; A Jansson; K Andersson; P Eneroth; L F Agnati
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

2.  Effects of withdrawal from chronic exposure to cigarette smoke on hypothalamic and preoptic catecholamine nerve terminal systems and on the secretion of pituitary hormones in the male rat.

Authors:  K Andersson; K Fuxe; P Eneroth; A Jansson; A Härfstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

3.  Interactions of nicotine and pentobarbitone in the regulation of telencephalic and hypothalamic catecholamine levels and turnover and of adenohypophyseal hormone secretion in the normal male rat.

Authors:  K Andersson; K Fuxe; P Eneroth; L F Agnati; J A Gustafsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

4.  Effects of acute continuous exposure of the rat to cigarette smoke on amine levels and utilization in discrete hypothalamic catecholamine nerve terminal systems and on neuroendocrine function.

Authors:  K Andersson; K Fuxe; P Eneroth; L F Agnati; A Härfstrand
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

5.  The characterization of the dopaminergic profile of EMD 23,448, and indolyl-3-butylamine: selective actions on presynaptic and supersensitive postsynaptic DA receptor populations.

Authors:  M Goldstein; K Fuxe; E Meller; C A Seyfried; L Agnati; F M Mascagni
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

Review 6.  Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors.

Authors:  Dasiel O Borroto-Escuela; Miguel Perez De La Mora; Paul Manger; Manuel Narváez; Sarah Beggiato; Minerva Crespo-Ramírez; Gemma Navarro; Karolina Wydra; Zaida Díaz-Cabiale; Alicia Rivera; Luca Ferraro; Sergio Tanganelli; Małgorzata Filip; Rafael Franco; Kjell Fuxe
Journal:  Front Synaptic Neurosci       Date:  2018-07-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.